|
Clearside Biomedical, Inc. (CLSD) Évaluation DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Clearside Biomedical, Inc. (CLSD) Bundle
Que vous soyez un investisseur ou un analyste, cette calculatrice DCF (CLSD) est votre ressource incontournable pour une évaluation précise. Chargé de données réelles de Clearside Biomedical, Inc., vous pouvez ajuster les prévisions et observer les effets en temps réel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.2 | 7.9 | 29.6 | 1.3 | 8.2 | 12.4 | 18.8 | 28.4 | 42.9 | 64.8 |
| Revenue Growth, % | 0 | 263.28 | 274.65 | -95.51 | 519.89 | 51.12 | 51.12 | 51.12 | 51.12 | 51.12 |
| EBITDA | -30.1 | -17.9 | -.4 | -29.5 | -23.1 | -10.0 | -15.1 | -22.8 | -34.5 | -52.1 |
| EBITDA, % | -1384.86 | -227.2 | -1.52 | -2220.27 | -280.31 | -80.3 | -80.3 | -80.3 | -80.3 | -80.3 |
| Depreciation | .2 | .2 | .2 | .1 | .1 | .6 | .9 | 1.4 | 2.1 | 3.2 |
| Depreciation, % | 9.71 | 2.28 | 0.60186 | 10.93 | 0.81449 | 4.87 | 4.87 | 4.87 | 4.87 | 4.87 |
| EBIT | -30.3 | -18.1 | -.6 | -29.6 | -23.1 | -10.0 | -15.1 | -22.8 | -34.5 | -52.1 |
| EBIT, % | -1394.57 | -229.48 | -2.12 | -2231.2 | -281.12 | -80.42 | -80.42 | -80.42 | -80.42 | -80.42 |
| Total Cash | 22.6 | 17.3 | 30.4 | 48.3 | 28.9 | 12.4 | 18.8 | 28.4 | 42.9 | 64.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | 10.0 | .0 | .2 | .9 | 1.3 | 2.0 | 3.1 | 4.7 |
| Account Receivables, % | 0 | 0 | 33.81 | 0 | 2.07 | 7.18 | 7.18 | 7.18 | 7.18 | 7.18 |
| Inventories | .0 | .0 | .9 | .0 | .0 | .1 | .1 | .2 | .3 | .4 |
| Inventories, % | 0 | 0 | 3.11 | 0 | 0 | 0.62282 | 0.62282 | 0.62282 | 0.62282 | 0.62282 |
| Accounts Payable | 1.3 | 2.0 | .9 | 1.1 | 2.2 | 4.8 | 7.3 | 11.0 | 16.6 | 25.1 |
| Accounts Payable, % | 58.9 | 25.3 | 3.18 | 79.13 | 26.81 | 38.66 | 38.66 | 38.66 | 38.66 | 38.66 |
| Capital Expenditure | .0 | -.1 | .0 | -.2 | -1.8 | -1.0 | -1.6 | -2.4 | -3.6 | -5.4 |
| Capital Expenditure, % | -1.15 | -0.69673 | 0 | -18.54 | -21.6 | -8.4 | -8.4 | -8.4 | -8.4 | -8.4 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -30.1 | -17.9 | -.6 | -30.6 | -23.1 | -10.0 | -15.1 | -22.8 | -34.4 | -52.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -28.6 | -17.1 | -12.4 | -19.7 | -23.9 | -8.6 | -13.8 | -20.8 | -31.4 | -47.5 |
| WACC, % | 17.69 | 17.66 | 17.76 | 17.76 | 17.76 | 17.73 | 17.73 | 17.73 | 17.73 | 17.73 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -67.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -48 | |||||||||
| Terminal Value | -308 | |||||||||
| Present Terminal Value | -136 | |||||||||
| Enterprise Value | -204 | |||||||||
| Net Debt | 14 | |||||||||
| Equity Value | -218 | |||||||||
| Diluted Shares Outstanding, MM | 62 | |||||||||
| Equity Value Per Share | -3.52 |
What You Will Get
- Pre-Filled Financial Model: Clearside Biomedical’s actual data provides an accurate DCF valuation.
- Full Forecast Control: Modify revenue growth, margins, WACC, and other critical factors.
- Instant Calculations: Automatic updates allow you to view results in real-time as you make adjustments.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
- Customizable and Reusable: Designed for adaptability, enabling repeated use for comprehensive forecasts.
Key Features
- 🔍 Real-Life CLSD Financials: Pre-filled historical and projected data for Clearside Biomedical, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Clearside's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Clearside's valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Model: Download and open the Excel file containing Clearside Biomedical, Inc.'s (CLSD) financial data.
- 2. Adjust Key Inputs: Modify essential parameters such as revenue growth rates, discount rates, and capital investment figures.
- 3. Analyze Results Immediately: The DCF model automatically computes the intrinsic value and net present value (NPV).
- 4. Explore Different Scenarios: Evaluate various projections to understand different valuation possibilities.
- 5. Make Informed Decisions: Utilize professional valuation analyses to guide your investment choices.
Why Choose This Calculator for Clearside Biomedical (CLSD)?
- Accuracy: Utilizes accurate Clearside financials for reliable data.
- Flexibility: Tailored for users to easily adjust and test various inputs.
- Time-Saving: Eliminate the need to construct a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users without advanced financial modeling skills.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for analyzing Clearside Biomedical, Inc. (CLSD).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights to clients interested in Clearside Biomedical, Inc. (CLSD).
- Students and Educators: Utilize real-world financial data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotechnology companies like Clearside Biomedical, Inc. (CLSD) are valued in the market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Clearside Biomedical historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Clearside Biomedical, Inc. (CLSD).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.